Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Immunology | Dermatology | Infections and Infectious Diseases | Family Medicine

Genital Warts Clinical Trials


A listing of Genital Warts medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

California

Alhambra : Call for Information (Investigational Site 0238)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Roseville : Call for Information (Investigational Site 0236)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Spring Valley : Call for Information (Investigational Site 0237)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Florida

Coral Gables : Call for Information (Investigational Site 0250)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Miami : Call for Information (Investigational Site 0248)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

South Miami : Call for Information (Investigational Site 0247)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Tampa : Call for Information (Investigational Site 0026)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Indiana

Indianapolis : Call for Information (Investigational Site 0233)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Kentucky

Bardstown : Call for Information (Investigational Site 0228)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Louisiana

Marrero : Call for Information (Investigational Site 0249)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Maryland

Elkridge : Call for Information (Investigational Site 0242)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Missouri

Kansas City : Call for Information (Investigational Site 0229)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

New York

New York : Call for Information (Investigational Site 0264)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Rochester : Call for Information (Investigational Site 0241)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Ohio

Cincinnati : Call for Information (Investigational Site 0231)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Pennsylvania

Philadelphia : Call for Information (Investigational Site 0240)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Philadelphia : Call for Information (Investigational Site 0025)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Tennessee

Nashville : Call for Information (Investigational Site 0232)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Texas

Galveston : Call for Information (Investigational Site 0255)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Utah

Salt Lake City : Call for Information (Investigational Site 0235)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Virginia

Richmond : Call for Information (Investigational Site 0245)

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Canada

Kirkland : Merck Frosst Canada Ltd.

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Colombia

Bogota : MDS Colombia SAS

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Denmark

Glostrup : Merck Sharp & Dohme

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Germany

Haar : MSD Sharp & Dohme GMBH

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Israel

Hod Hasharon : Merck Sharp & Dohme Co. Ltd.

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Malaysia

Petaling Jaya : MSD

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Norway

Drammen : MSD (Norge) AS

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Poland

Warszawa : MSD Polska Sp. Z o.o.

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Spain

Madrid : Merck Sharp and Dohme de Espana S.A.

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Sweden

Sollentuna : MSD

Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)

Taiwan

Tainan : National Cheng Kung University Hospital

SR-T100 Gel Efficacy & Safety Study for Vulva Pre-cancerous Lesions & Cutaneous Condyloma